Elkem (ELK) DNB Carnegie Small & Medium Enterprises Conference presentation summary
Event summary combining transcript, slides, and related documents.
DNB Carnegie Small & Medium Enterprises Conference presentation summary
30 Mar, 2026Strategic transformation and portfolio evolution
Over 120 years of industrial history with significant international growth and strategic acquisitions, including recent purchase of VUM in Slovakia and divestment of the Silicones division to Bluestar.
Sale of the Silicones division enables minority investors to assume full control, with Elkem remaining listed on the Oslo Stock Exchange.
New corporate structure focuses on three divisions: Silicon, Foundry Alloys, and Carbon.
Market environment and trade dynamics
EU implemented safeguard measures on ferrosilicon and foundry alloys, raising prices and protecting internal production; Norway and Iceland not exempted.
US imposed countervailing and anti-dumping duties on silicon imports, resulting in a total tariff of 41% on Norwegian exports.
Market conditions remain challenging with weak demand in the EU and stable but expected rising prices in the US.
Geopolitical tensions, including the Middle East conflict, have increased macroeconomic uncertainty and impacted value chains.
Financial performance and cost initiatives
Operating income CAGR of 5% and EBITDA margin of 16% over the cycle, meeting targets despite industry downturn.
Excluding Silicones, operating income CAGR is 6% and EBITDA margin is 21%.
Significant cost-cutting measures underway, including a 10% workforce reduction and NOK 1.3 billion in working capital and capex improvements.
Estimated cost reductions of NOK 0.6 billion, with half realized by year-end 2026; investments capped at NOK 1.0 billion.
Latest events from Elkem
- Silicones division sale drives transformation, cost cuts, and growth focus amid challenging markets.ELK
JP Morgan European Chemicals Forum presentation30 Mar 2026 - All agenda items, including the Bluestar share deal and capital decrease, were approved.ELK
EGM 20269 Mar 2026 - Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 202513 Feb 2026 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 20243 Feb 2026 - EBITDA hit NOK 1,235 million, up 131% year-over-year, driven by Silicones and cost programs.ELK
Q3 202418 Jan 2026 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation14 Jan 2026 - 2024 saw strong financials, strategic portfolio review, and top-tier ESG achievements.ELK
DNB Small & Medium Enterprises Conference presentation14 Jan 2026 - Stable results amid weak markets, with Silicones improving and strategic review ongoing.ELK
Lunch presentation14 Jan 2026 - Divesting Silicones to focus on core growth, backed by strong financials and global leadership.ELK
SEB Nordic Seminar presentation14 Jan 2026